Clinical characteristics associated with discrepancies between self- and clinician-rated suicidal ideation in patients with bipolar disorder (FACE-BD cohort).
Psychiatry Research. 2023-03-01; 321: 115055
DOI: 10.1016/j.psychres.2023.115055
Read on PubMed
1. Psychiatry Res. 2023 Mar;321:115055. doi: 10.1016/j.psychres.2023.115055. Epub
2023 Jan 9.
Clinical characteristics associated with discrepancies between self- and
clinician-rated suicidal ideation in patients with bipolar disorder (FACE-BD
cohort).
Nobile B(1), Belzeaux R(2), Aouizerate B(3), Dubertret C(4), Haffen E(5), Llorca
PM(6), Roux P(7), Polosan M(8), Schwan R(9), Walter M(10), Rey R(11), Januel
D(12), Leboyer M(13), Bellivier F(14), Etain B(14); FondaMental Advanced Centres
of Expertise in Bipolar Disorders (FACE-BD) Collaborators(15); Courtet P(16),
Olié E(16).
Author information:
(1)Department of Emergency Psychiatry and Post-Acute Care, CHU Montpellier,
France; IGF, Univ. Montpellier, CNRS, INSERM, Montpellier, France; FondaMental
Foundation, Créteil F-94000, France. Electronic address:
.
(2)Department of Emergency Psychiatry and Post-Acute Care, CHU Montpellier,
France; FondaMental Foundation, Créteil F-94000, France; Pôle de Psychiatrie,
Assistance Publique Hôpitaux de Marseille, Marseille, France; INT-UMR7289, CNRS
Aix-Marseille Université, Marseille, France.
(3)FondaMental Foundation, Créteil F-94000, France; Centre Hospitalier Charles
Perrens, Bordeaux, France; Laboratoire NutriNeuro (UMR INRA 1286), Université de
Bordeaux, Bordeaux, France.
(4)FondaMental Foundation, Créteil F-94000, France; Université Paris Cité,
Paris, France; AP-HP, Groupe Hospitalo-Universitaire AP-HP Nord, DMU ESPRIT,
Service de Psychiatrie et Addictologie, Hôpital Louis Mourier, Colombes, France;
Université de Paris, Inserm UMR1266, Sorbonne Paris Cité, Faculté de Médecine,
Paris, France.
(5)FondaMental Foundation, Créteil F-94000, France; Service de Psychiatrie de
l’Adulte, CIC-1431 INSERM, CHU de Besançon, Laboratoire de Neurosciences, UFC,
UBFC, Besançon, France.
(6)FondaMental Foundation, Créteil F-94000, France; CHU Clermont-Ferrand,
Department of Psychiatry, University of Clermont Auvergne, CNRS, Clermont
Auvergne INP, Institut Pascal, 63000 Clermont-Ferrand, France.
(7)FondaMental Foundation, Créteil F-94000, France; Université Paris-Saclay,
UVSQ, CESP UMR1018, DevPsy-DisAP, Centre Hospitalier de Versailles, Pôle de
Psychiatrie et Santé Mentale, 78157 Le Chesnay, France.
(8)FondaMental Foundation, Créteil F-94000, France; Univ. Grenoble Alpes,
Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble,
France.
(9)FondaMental Foundation, Créteil F-94000, France; Université de Lorraine,
Centre Psychothérapique de Nancy, Inserm U1254, Nancy, France.
(10)FondaMental Foundation, Créteil F-94000, France; Service
Hospitalo-Universitaire de Psychiatrie Générale et de Réhabilitation Psycho
Sociale 29G01 et 29G02, CHRU de Brest, Hôpital de Bohars, Brest, France.
(11)FondaMental Foundation, Créteil F-94000, France; INSERM U1028, CNRS UMR5292,
Université Claude Bernard Lyon 1, Centre de Recherche en Neurosciences de Lyon,
Equipe PSYR2, Centre Hospitalier Le Vinatier, Pole Est, 95 bd Pinel, BP 30039,
69678 Bron Cedex, France.
(12)FondaMental Foundation, Créteil F-94000, France; Unité de Recherche
Clinique, EPS Ville-Evrard, 93332 Neuilly-sur-Marne, France.
(13)FondaMental Foundation, Créteil F-94000, France; Univ Paris Est Créteil,
INSERM U955, IMRB, Translational NeuroPsychiatry Laboratory, Créteil, France;
AP-HP, Hôpitaux Universitaires Henri Mondor, Département Médico-Universitaire de
Psychiatrie et d’Addictologie (DMU IMPACT), Fédération Hospitalo-Universitaire
de Médecine de Précision en Psychiatrie (FHU ADAPT), Créteil, France.
(14)FondaMental Foundation, Créteil F-94000, France; Université Paris Cité,
Paris, France; AP-HP, Groupe Hospitalo-Universitaire AP-HP Nord, DMU
Neurosciences, Hôpital Fernand Widal, Département de Psychiatrie et de Médecine
Addictologique, Paris, France; Université Paris Cité, INSERM UMR-S 1144,
Optimisation Thérapeutique en Neuropsychopharmacologie OTeN, Paris, France.
(15)FondaMental Foundation, Créteil F-94000, France.
(16)Department of Emergency Psychiatry and Post-Acute Care, CHU Montpellier,
France; IGF, Univ. Montpellier, CNRS, INSERM, Montpellier, France; FondaMental
Foundation, Créteil F-94000, France.
Suicidal ideation (SI) is a major suicide risk factor; therefore, it is crucial
to identify individuals with SI. Discrepancies between the clinicians and
patients’ estimation of SI may lead to under-evaluating the suicide risk. Yet,
studies on discrepancies between self- and clinician-rated SI are lacking,
although identifying the patients’ sociodemographic and clinical characteristics
associated with such discrepancies might help to reduce the under-evaluation
risk. Therefore, the aim of this study was to identify features associated with
SI rating discrepancies in patients with bipolar disorder (BD) because of the
high prevalence of suicide in this population. Among the patients recruited by
the French network of FondaMental expert centers for BD, patients with SI (i.e.
≥2 for item 12 of the Quick Inventory of Depressive Symptomatology-Self Report
and/or ≥3 for item 10 of the clinician-rated Montgomery and Åsberg Depression
Rating Scale) were selected and divided in concordant (i.e. SI in both self- and
clinician-rated questionnaires; n = 130; 25.6%), and discordant (i.e. SI in only
one questionnaire; n = 377; 74.4%). Depression severity was the feature most
associated with SI evaluation discrepancy, especially in patients with SI
identified only with the self-rated questionnaire. Clinician may under-evaluate
SI presence in patients with low depression level.
Copyright © 2023. Published by Elsevier B.V.
DOI: 10.1016/j.psychres.2023.115055
PMID: 36680982 [Indexed for MEDLINE]
Conflict of interest statement: Declaration of Competing Interest None of the
authors declare conflict of interests related to this manuscript.